Self-Hypnosis Training as an Adjunctive Treatment in the Management of Pain Associated with Sickle Cell Disease

A cohort of patients with sickle cell disease, consisting of children, adolescents, and adults, who reported experiencing three or more episodes of vaso-occlusive pain the preceding year, were enrolled in a prospective two-period treatment protocol. Following a 4-month conventional treatment baseline phase, a supplemental cognitive-behavioralpain management program that centered on self-hypnosis was implemented over the next 18 months. Frequency of self-hypnosis group